3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Breast
2
Conditions
Breast Neoplasms
14
Carcinoma, Non-Small-Cell Lung
11
Lung Neoplasms
9
Pancreatic Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Head and Neck Neoplasms
7
Colorectal Neoplasms
7
Ovarian Neoplasms
6
Neoplasm Metastasis
6
Carcinoma, Hepatocellular
6
Triple Negative Breast Neoplasms
5
Urinary Bladder Neoplasms
4
Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Biliary Tract Neoplasms
4
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Prostatic Neoplasms
3
Lymphoma, Follicular
3
Kidney Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Squamous Cell
3
Carcinoma, Renal Cell
3
Carcinoma
3
Adenocarcinoma Of Esophagus
3
Uterine Cervical Neoplasms
2
Recurrence
2
Oropharyngeal Neoplasms
2
Non-Muscle Invasive Bladder Neoplasms
2
Lymphoma, T-Cell, Cutaneous
2
Interventions
Temozolomide
26
Bevacizumab
14
Radiosurgery
12
Radiotherapy
9
pembrolizumab
8
Carboplatin
8
Trastuzumab
6
temsirolimus
5
Sirolimus
5
Erlotinib Hydrochloride
5
abemaciclib
4
Paclitaxel
4
Irinotecan
4
Capecitabine
4
tipifarnib
3
Sorafenib
3
Radiation
3
Mental Status and Dementia Tests
3
Ipilimumab
3
Everolimus
3
Aminolevulinic Acid
3
130-nm albumin-bound paclitaxel
3
tucatinib
2
pertuzumab
2
fludarabine
2
durvalumab
2
alovudine
2
alectinib
2
Vorinostat
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1/2
×
Brain Neoplasms
×
durvalumab
×
Clear all
NCT04711824
2025-12-23
SOLARA
Hoosier Cancer Research Network
Phase 1/2
Recruiting
41 enrolled
NCT04538742
2025-12-08
DB-07
AstraZeneca
Phase 1/2
Active not recruiting
245 enrolled